Kreuter, Michael http://orcid.org/0000-0003-4402-2159
Maher, Toby M.
Corte, Tamera J.
Molina-Molina, Maria
Axmann, Judit
Gilberg, Frank
Kirchgaessler, Klaus-Uwe
Cottin, Vincent
Clinical trials referenced in this document:
Documents that mention this clinical trial
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
https://doi.org/10.1136/bmj-2021-066354
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
https://doi.org/10.1136/bmjresp-2018-000289
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
https://doi.org/10.1007/s12325-021-02009-w
Funding for this research was provided by:
F. Hoffmann-La Roche, Ltd.
Article History
Received: 1 October 2021
Accepted: 29 November 2021
First Online: 22 December 2021